Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-03-31

Clinical Trial Update: Comparison of Amitriptyline to Lifestyle Modification as Intervention for Vestibular Migraine [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating amitriptyline versus lifestyle modification for vestibular migraine has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amitriptyline (amitriptyline)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Vestibular Migraine | EARLY_Phase 1 | Status: WITHDRAWN